The groundbreaking success of Viagra undeniably revolutionized the drug landscape, but betting in companies heavily reliant on generic versions presents a complex picture. Despite early profits were impressive, the expiration of patents and the emergence of cheaper alternatives have weakened sales. Thus, a thorough evaluation of present revenue str